{"id":"https://openalex.org/W2186428109","doi":null,"title":"Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add therapy to metformin in poorly controlled type 2 diabetes mellitus patients in Punjab","display_name":"Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add therapy to metformin in poorly controlled type 2 diabetes mellitus patients in Punjab","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2186428109","mag":"2186428109"},"language":"en","primary_location":{"id":"mag:2186428109","doi":null,"is_oa":false,"landing_page_url":"https://iaimjournal.com/wp-content/uploads/2015/01/12-Comparative-study-efficacy-and-tolerability.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2186428109"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013944142","display_name":"Amita Jindal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amita Jindal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Rupinder Kaur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rupinder Kaur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112003471","display_name":"Mahesh Jindal","orcid":"https://orcid.org/0009-0008-9768-7182","observed_orcids":["https://orcid.org/0009-0008-9768-7182"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mahesh Jindal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113965442","display_name":"Maharaja Ganga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maharaja Ganga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058462928","display_name":"Singh Dental","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Singh Dental","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3981,"has_fulltext":false,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.61071538,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9750000238418579},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9110000133514404},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8799999952316284},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.902999997138977},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9269999861717224},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.9419999718666077},{"id":"https://openalex.org/keywords/peripheral-edema","display_name":"peripheral edema","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8930000066757202},{"id":"https://openalex.org/keywords/punjabi-population","display_name":"Punjabi population","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9488292336463928},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8934862613677979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8704085946083069},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.8537052869796753},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6790664792060852},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6013530492782593},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5990261435508728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5826406478881836},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5397722125053406},{"id":"https://openalex.org/C2777482430","wikidata":"https://www.wikidata.org/wiki/Q7168709","display_name":"Peripheral edema","level":3,"score":0.5210011601448059},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4900156557559967},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4694865345954895},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4265854060649872},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3798898160457611},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3798826336860657},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27576887607574463},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13265568017959595},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186428109","doi":null,"is_oa":false,"landing_page_url":"https://iaimjournal.com/wp-content/uploads/2015/01/12-Comparative-study-efficacy-and-tolerability.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1969389642","https://openalex.org/W1977619586","https://openalex.org/W2049323977","https://openalex.org/W2063976195","https://openalex.org/W2103828712","https://openalex.org/W2119114384","https://openalex.org/W2146901298","https://openalex.org/W2152978153"],"related_works":["https://openalex.org/W2124465362","https://openalex.org/W2079787842","https://openalex.org/W6967486780","https://openalex.org/W2396232299","https://openalex.org/W2023459427","https://openalex.org/W2089443047","https://openalex.org/W2419366834","https://openalex.org/W2092883481","https://openalex.org/W4210366052"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,229],"incidence":[2],"of":[3,34,136,141,215],"diabetes":[4,37],"in":[5,32,44,51,70,96,100,103,108,119,125,162,200,223,234,239],"urban":[6],"Punjab":[7],"is":[8,217],"on":[9],"the":[10,112,133,213],"r":[11],"increasing":[12],"year":[13],"by":[14],"year.":[15],"Material":[16],"and":[17,73,83,123,145,183,195,212,237],"methods:":[18],"This":[19],"24":[20],"week":[21],"study":[22],"was":[23,68,88,93],"designed":[24],"to":[25,54,105,154,160,198,225],"compare":[26],"vildagliptin":[27,57],"as":[28,156],"an":[29,157],"add-on":[30,158],"therapy":[31,159,197],"patients":[33,48],"type":[35],"2":[36,174],"mellitus":[38],"inadequately":[39],"controlled":[40,202],"with":[41,132],"metformin":[42,161,199,226],"alone":[43],"Punjabi":[45,163],"population.":[46],"Sixty":[47],"were":[49],"randomized":[50],"two":[52],"groups":[53,114],"receive":[55],"either":[56],"100":[58],"mg":[59,220],"(group":[60,221],"1)":[61],"or":[62],"pioglitazo":[63],"primary":[64],"efficacy":[65,131],"end":[66,76],"point":[67,77],"change":[69],"FBG,":[71,235],"PPG":[72,236],"HbA1c.":[74],"Secondary":[75],"included":[78],"lipid":[79],"profile,":[80],"body":[81,98],"weight":[82,99,147],"peripheral":[84,142],"edema.":[85],"Results:":[86],"There":[87,92],"no":[89,146],"significant":[90,94,106,117],"groups.":[91],"decrease":[95,118],"mean":[97,232],"group":[101,109],"1":[102],"contrast":[104],"increase":[107,124],"2.":[110],"Both":[111],"treatment":[113],"reported":[115],"a":[116,137,151],"TG,":[120],"TC,":[121],"LDL":[122],"HDL.":[126],"Conclusion:":[127],"Vildagliptin":[128],"displays":[129],"robust":[130],"added":[134],"benefits":[135],"much":[138],"lower":[139],"risk":[140],"edema,":[143],"hypoglycemia":[144],"gain,":[148],"making":[149],"it":[150],"promising":[152],"alternative":[153],"pioglitazone":[155],"population":[164],"2,":[165],"Issue":[166],"1,":[167],"January,":[168],"2015.":[169],"1*":[170],",":[171,175],"Rupinder":[172],"Kaur":[173],"Mahesh":[176],"Jindal":[177],"Maharaja":[178],"Ganga":[179],"Singh":[180],"Dental":[181],"College":[182],"Sriganganagar,":[184],"Rajasthan,":[185],"India":[186,189],"Sunam,":[187],"Punjab,":[188],"amita.jindal19@yahoo.in":[190],".":[191,203,241],"Comparative":[192],"study:":[193],"Efficacy":[194],"-on":[196],"poorly":[201],"IAIM,":[204],"2015;":[205],"2(1):":[206],"83-94.":[207],"www.iaimjournal.com":[208],"Accepted":[209],"on:":[210],"ise":[211],"number":[214],"diabetics":[216],"ne":[218],"30":[219],"2)":[222],"addition":[224],"1000":[227],"mg.":[228],"difference":[230],"between":[231],"reduction":[233],"HbA1c":[238],"both":[240],"ISSN:":[242,245],"2394-0026":[243],"(P)":[244],"2394-0034":[246],"(O)":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2186428109","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
